PFHO · Pacific Health Care Organization Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.50M | - | $1.59M | $1.73M | $1.82M | - | $1.53M | $1.57M | $1.40M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $180.8K | - | $186.1K | $227.8K | $152.6K | - | $193.4K | $212.9K | $135.8K | - |
| Total Operating Expenses | $1.33M | - | $1.38M | $1.42M | $1.50M | - | $1.38M | $1.38M | $1.22M | - |
| D&A | $5.3K | - | - | - | $7.2K | - | $8.4K | $9.1K | $9.4K | - |
| Operating Income | $172.7K | - | $205.0K | $303.6K | $314.4K | - | $151.6K | $192.0K | $175.2K | - |
| Interest Expense | $0 | - | $0 | $0 | $0 | - | - | - | - | - |
| Income Tax | $74.2K | - | $87.1K | $258.8K | $114.0K | - | $90.3K | $83.4K | $77.0K | - |
| Net Income | $193.7K | - | $223.0K | $636.9K | $292.7K | - | $174.9K | $215.6K | $197.4K | - |
| EPS - Basic | $0.02 | - | $0.02 | $0.05 | $0.02 | - | $0.01 | $0.02 | $0.02 | - |
| EPS - Diluted | $0.02 | - | $0.02 | $0.05 | $0.02 | - | $0.01 | $0.02 | $0.02 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.40M | $2.17M | $2.18M | $2.16M | $2.36M | $2.07M | $2.55M | $2.62M | $2.84M | $2.57M |
| Accounts Receivable | $1.07M | $1.01M | $1.02M | $1.09M | $933.3K | $1.03M | $1.09M | $941.3K | $879.1K | $1.05M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $213.5K | $228.0K | $194.0K | $148.3K | $218.9K | $148.1K | $175.0K | $163.1K | $148.1K | $159.8K |
| Current Assets | $13.69M | $13.39M | $13.23M | $13.22M | $12.56M | $12.34M | $12.07M | $11.87M | $11.91M | $11.68M |
| Total Assets | $13.77M | $13.46M | $13.29M | $13.31M | $12.66M | $12.43M | $12.14M | $11.94M | $12.04M | $11.82M |
| Current Liabilities | $496.5K | $388.6K | $453.4K | $698.1K | $677.1K | $745.6K | $747.5K | $726.0K | $1.03M | $1.01M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | $745.6K | $747.5K | $726.0K | $1.04M | $1.02M |
| Stockholders' Equity | $13.27M | $13.07M | $12.84M | $12.62M | $11.98M | $11.69M | $11.39M | $11.22M | $11.00M | $10.80M |
| Retained Earnings | $12.84M | $12.65M | $12.41M | $12.19M | $11.55M | $11.26M | $10.96M | $10.79M | $10.57M | $10.37M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $228.0K | - | - | - | $330.7K | - | - | - | $290.9K | - |
| Investing Cash Flow | $0 | - | - | - | ($8.5K) | - | - | - | ($3.7K) | - |
| Financing Cash Flow | $0 | - | - | - | ($35.3K) | - | - | - | ($14.2K) | - |
| CapEx | $0 | - | - | - | $8.5K | - | - | - | $3.7K | - |
| Free Cash Flow | $228.0K | - | - | - | $322.2K | - | - | - | $287.2K | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 11.5% | - | 12.9% | 17.6% | 17.3% | - | 9.9% | 12.2% | 12.5% | - |
| EBITDA margin | 11.9% | - | - | - | 17.7% | - | 10.5% | 12.8% | 13.2% | - |
| Net margin | 12.9% | - | 14.1% | 36.9% | 16.1% | - | 11.4% | 13.7% | 14.1% | - |
| Free cash flow margin | 15.2% | - | - | - | 17.7% | - | - | - | 20.5% | - |
| FCF / Net income | 1.18 | - | - | - | 1.10 | - | - | - | 1.45 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 12.1% | - | 11.7% | 13.2% | 8.4% | - | 12.7% | 13.6% | 9.7% | - |
| Effective tax rate | 27.7% | - | 28.1% | 28.9% | 28.0% | - | 34.1% | 27.9% | 28.1% | - |
| Return on assets | 1.4% | - | 1.7% | 4.8% | 2.3% | - | 1.4% | 1.8% | 1.6% | - |
| Return on equity | 1.5% | - | 1.7% | 5.0% | 2.4% | - | 1.5% | 1.9% | 1.8% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 27.58 | 34.45 | 29.17 | 18.93 | 18.55 | 16.54 | 16.15 | 16.35 | 11.60 | 11.59 |
| Quick ratio | 27.58 | 34.45 | 29.17 | 18.93 | 18.55 | 16.54 | 16.15 | 16.35 | 11.60 | 11.59 |
| Cash ratio | 4.83 | 5.58 | 4.81 | 3.09 | 3.48 | 2.78 | 3.41 | 3.61 | 2.77 | 2.54 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.04 | 1.03 | 1.04 | 1.06 | 1.06 | 1.06 | 1.07 | 1.06 | 1.09 | 1.09 |
| Liabilities / Assets | - | - | - | - | - | 0.06 | 0.06 | 0.06 | 0.09 | 0.09 |
| Efficiency | ||||||||||
| Asset turnover | 0.11 | - | 0.12 | 0.13 | 0.14 | - | 0.13 | 0.13 | 0.12 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 260d | - | 234d | 231d | 187d | - | 261d | 219d | 230d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 60.0x | - | 58.5x | 16.0x | 36.0x | - | 83.0x | 44.0x | 33.0x | - |
| P / B | 1.2x | - | 1.2x | 0.8x | 0.8x | - | 0.9x | 1.0x | 0.8x | - |
| P / S | 10.3x | - | 9.4x | 5.9x | 5.1x | - | 7.0x | 7.2x | 6.1x | - |
| EV / EBITDA | 72.9x | - | - | - | 21.4x | - | 50.6x | 43.1x | 30.4x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -17.7% | - | 3.9% | 10.0% | 30.1% | - | 11.0% | 20.9% | 6.5% | - |
| Revenue CAGR (3y) | 4.5% | - | 3.0% | 7.2% | 8.4% | - | 5.2% | 5.3% | 1.8% | - |
| Revenue CAGR (5y) | 2.5% | - | 2.3% | 3.3% | 3.2% | - | -3.6% | -2.9% | -4.8% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -45.1% | - | 35.3% | 58.1% | 79.5% | - | 3.1% | 32.3% | 112.5% | - |
| Net income growth (YoY) | -33.8% | - | 27.5% | 195.5% | 48.3% | - | -2.4% | 22.2% | 50.6% | - |
| EPS growth (YoY) | 0.0% | - | 100.0% | 150.0% | 0.0% | - | 0.0% | 100.0% | 100.0% | - |
| EPS CAGR (3y) | 26.0% | - | 26.0% | 71.0% | 26.0% | - | 0.0% | 26.0% | -20.6% | - |
| EPS CAGR (5y) | -12.9% | - | 14.9% | 38.0% | 14.9% | - | -36.9% | -24.2% | -26.0% | - |
| FCF growth (YoY) | -29.2% | - | - | - | 12.2% | - | - | - | - | - |
| FCF CAGR (5y) | -11.1% | - | - | - | -3.5% | - | - | - | -0.6% | - |
| Book value growth (YoY) | 10.8% | 11.9% | 12.7% | 12.5% | 8.9% | 8.2% | 8.3% | 8.4% | -3.9% | -4.5% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$6.72M totalMedical Case Management$2.22M · 33.0%
Utilization Review$2.16M · 32.2%
HCO$1.23M · 18.3%
MPN$663.5K · 9.9%
Medical Bill Review$403.3K · 6.0%
Other Revenues$45.3K · 0.7%
Peer comparison
Same SIC group: Services-Misc Health & Allied Services, NEC
Comparing PACIFIC HEALTH CARE ORGANIZATION INC against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Jun 2, 2023 | $0.1000 |
| Sep 10, 2015 | $0.0781 |